The use of COLD-PCR and high-resolution melting analysis improves the limit of detection of KRAS and BRAF mutations in colorectal cancer.
about
Performance and cost efficiency of KRAS mutation testing for metastatic colorectal cancer in routine diagnosis: the MOKAECM study, a nationwide experienceMolecular characterization of multidrug-resistant Mycobacterium tuberculosis isolates from China.COLD-PCR enhanced melting curve analysis improves diagnostic accuracy for KRAS mutations in colorectal carcinoma.Ice-COLD-PCR enables rapid amplification and robust enrichment for low-abundance unknown DNA mutations.Enrichment of mutations in multiple DNA sequences using COLD-PCR in emulsion.A new microarray substrate for ultra-sensitive genotyping of KRAS and BRAF gene variants in colorectal cancer.KRAS mutation testing in metastatic colorectal cancerClinical utility of a blood-based BRAF(V600E) mutation assay in melanomaCOLD-PCR: improving the sensitivity of molecular diagnostics assays.COLD-PCR amplification of bisulfite-converted DNA allows the enrichment and sequencing of rare un-methylated genomic regionsTemperature-tolerant COLD-PCR reduces temperature stringency and enables robust mutation enrichmentPhenotypic and molecular differences between giant-cell tumour of soft tissue and its bone counterpart.DMSO Increases Mutation Scanning Detection Sensitivity of High-Resolution Melting in Clinical Samples.BRAF mutation testing in clinical practice.Extreme assay sensitivity in molecular diagnostics further unveils intratumour heterogeneity in metastatic colorectal cancer as well as artifactual low-frequency mutations in the KRAS geneKRAS mutation detection in paired frozen and Formalin-Fixed Paraffin-Embedded (FFPE) colorectal cancer tissuesBiosensors for liquid biopsy: circulating nucleic acids to diagnose and treat cancer.Molecular Diagnostic Applications in Colorectal Cancer.Ultrasensitive detection and identification of BRAF V600 mutations in fresh frozen, FFPE, and plasma samples of melanoma patients by E-ice-COLD-PCR.COLD-PCR Technologies in the Area of Personalized Medicine: Methodology and Applications.Realizing the potential of plasma genotyping in an age of genotype-directed therapies.Assessment of the InSiGHT Interpretation Criteria for the Clinical Classification of 24 MLH1 and MSH2 Gene Variants.Increased sensitivity of KRAS mutation detection by high-resolution melting analysis of COLD-PCR products.Application of coamplification at lower denaturation temperature-PCR sequencing for early detection of antiviral drug resistance mutations of hepatitis B virus.Potential clinical significance of plasma-based KRAS mutation analysis using the COLD-PCR/TaqMan(®) -MGB probe genotyping method.COLD-HRM PCR versus conventional HRM PCR to detect the BRAF V600E mutation A real improvement?POLE somatic mutations in advanced colorectal cancer.Ovarian metastasis from uveal melanoma with MLH1/PMS2 protein loss in a patient with germline MLH1 mutated Lynch syndrome: consequence or coincidence?Tumor heterogeneity revealed by KRAS, BRAF, and PIK3CA pyrosequencing: KRAS and PIK3CA intratumor mutation profile differences and their therapeutic implications.
P2860
Q28534874-165E390E-3E74-4816-A106-B7642DBECE09Q33622808-6E33D117-6C4D-420B-ABF8-31A8AFD72C6EQ33756779-5E2317E2-F49A-41CB-B235-0B5B7B20540DQ34474184-DF751AF6-A710-4642-9BD2-152D891C41B0Q34510937-A8168411-7CED-43B2-ACD3-A6F8F46EF144Q34639858-8949AC86-68B9-455B-A33A-3FD8D90F15DDQ34643960-1AD3ADAE-CA6D-4A28-BB0A-77D670D4B76CQ34646769-8A68F96D-330B-4D76-8B4D-9C9D9CE2BCB0Q35036964-AC284B7F-D597-4DB0-8F81-68B29A820212Q35146861-DB429ACA-8AE5-47BC-A911-1E5BE8BE03D4Q36163750-EEE7D026-194E-4CF1-8875-C4DA6F69C023Q36364836-6B1D30F3-3DCA-4E7D-941F-FA2176FEC46EQ37503539-9B5317A0-19E7-4DA2-9A3D-7892E25B0ACFQ37988572-ED175648-7CD2-4869-8F8E-B506C374207BQ38373863-DEF1E3D9-FCCB-4C53-999D-EAB32868066CQ38409695-D2CB840B-ADEE-48D4-A291-212DAFC0EFC5Q38920745-6C1D2DDB-A751-42CA-BD48-B3DC378A748CQ38947671-FAD45C74-EF48-46A8-8B5F-927CC0C40BB7Q38980841-26A447FD-C17D-40E9-B53A-219ED75BC0A9Q39094514-06C9561F-5150-430E-9892-71EFF7BAB175Q39147121-262B8F9F-B7E2-4510-BA6A-A01EC703528CQ39389539-56B9AFA8-4D5D-42F9-97E4-CF8B4F70A990Q39654749-C28E2760-4B9F-411C-81E6-17B9F6786B37Q42210924-9DDF6291-5F47-4435-A24B-4BD10D6D7A40Q42571089-C8160F5C-F33E-4281-9FAE-736668818396Q42784138-FE03F0B5-2A0A-4A43-8E9B-625A55E01017Q48125044-4622AA57-4CF1-444A-8BBC-9D12C91FEFD8Q48181350-5D1805CF-9F7B-424F-A68F-7E5A4E87BC45Q54389429-8C4584C2-4583-43BB-9064-C7F57ED7432F
P2860
The use of COLD-PCR and high-resolution melting analysis improves the limit of detection of KRAS and BRAF mutations in colorectal cancer.
description
2010 nî lūn-bûn
@nan
2010 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
The use of COLD-PCR and high-r ...... utations in colorectal cancer.
@ast
The use of COLD-PCR and high-r ...... utations in colorectal cancer.
@en
The use of COLD-PCR and high-r ...... utations in colorectal cancer.
@nl
type
label
The use of COLD-PCR and high-r ...... utations in colorectal cancer.
@ast
The use of COLD-PCR and high-r ...... utations in colorectal cancer.
@en
The use of COLD-PCR and high-r ...... utations in colorectal cancer.
@nl
prefLabel
The use of COLD-PCR and high-r ...... utations in colorectal cancer.
@ast
The use of COLD-PCR and high-r ...... utations in colorectal cancer.
@en
The use of COLD-PCR and high-r ...... utations in colorectal cancer.
@nl
P2093
P2860
P1476
The use of COLD-PCR and high-r ...... mutations in colorectal cancer
@en
P2093
Claudio Orlando
Claudio Santucci
Fabio Cianchi
Nicola Pratesi
Pamela Pinzani
Rosa Valanzano
P2860
P304
P356
10.2353/JMOLDX.2010.100018
P577
2010-07-08T00:00:00Z